A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors
NCT05393063
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
AK127
Sponsor
Akeso